Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo-Reference-Cited by-同舟云学术

Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo

Published:2000-10 Issue:4 Volume:2 Page:330-338
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Gerdes Christian A.,Castro Maria G.,Löwenstein Pedro R.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference27 articles.

1. Human gene therapy;Anderson;Nature,1998

2. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector;Blomer;J. Virol.,1997

3. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: Implications for clinical trials;Dewey;Nat. Med.,1999

4. The role of vector toxicity versus inflammatory and immune responses in eliminating adenovirus vector-mediated transgene expression from the rat brain;Thomas;Submitted,2000

5. Immune responses to adenovirus vectors in the nervous system;Wood;Trends Neurosci,1996

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Baculoviruses as Gene Therapy Vectors for Brain Cancer;Viruses;2023-02-22

2. Identification, isolation and bioinformatics analysis of specific tuber promoter in plants;Journal of Crop Breeding;2019-12-01

3. Down-Regulation of MHC Class I Expression in Human Keratinocytes Using Viral Vectors Containing US11 Gene of Human Cytomegalovirus and Cultivation on Bovine Collagen-Elastin Matrix (Matriderm®): Potential Approach for an Immune-Privileged Skin Substitute;International Journal of Molecular Sciences;2019-04-26

4. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells;Gene;2019-02

5. Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients;Clinical Immunology;2018-04